Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 339945

Страница 1 из 33995

The Russian Financial Market: Progress and Challenges
Manuylov K., Tkachev V., Andronova I.
Some problems of the optimal fast-actioning over shore system: cliff-beach
Moskovkin, V. M., Manuylov, M. B., Nazarenko, V. V.
Optimal control over shore system: cliff-beach in conditions of loose-rocks
Moskovkin, V. M., Manuylov, M. B., Nazarenko, V. V.
MOLECULAR EPIDEMIOLOGY OF THE HEPATITIS E VIRUS IN THE RUSSIAN FEDERATION
Mikhailov M.I., Karlsen A.A., Potemkin I.A., Isaeva O.V., Kichatova V.S., Malinnikova E.Yu., Asadi Mobarkhan F.A., Mullin E.V., Lopatukhina M.A., Kyuregyan K.K., Manuylov V.A., Mazunina E.P., Bykonia E.N., Kleymenov D.A., Popova L.I., Gushchin V.A., Tkachuk A.P., Polyakov A.D., Solonin S.A., Gordeychuk I.V.
Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
Manuylov V., Burgasova O., Borisova O., Smetanina S., Vasina D., Grigoriev I., Kudryashova A., Semashko M., Cherepovich B., Kharchenko O., Kleymenov D., Mazunina E., Tkachuk A., Gushchin V.
The avidity index (AI) of IgG to the RBD of SARS-CoV-2 was determined for 71 patients with a mild
Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study
Tkachuk A.P., Bykonia E.N., Popova L.I., Kleymenov D.A., Semashko M.A., Chulanov V.P., Fitilev S.B., Maksimov S.L., Smolyarchuk E.A., Manuylov V.A., Vasina D.V., Gushchin V.A., Gintsburg A.L.
GamTBvac is a candidate tuberculosis vaccine with two fusion proteins, containing Ag85a, ESAT6, CFP
GENETIC DIVERSITY AND POSSIBLE ORIGINS OF THE HEPATITIS B VIRUS IN SIBERIAN NATIVES
Manuylov V., Chulanov Vladimir, Bezuglova L., Chub E., Karlsen A., Kyuregyan K., Ostankova Y., Semenov A., Osipova L., Tallo T., Netesova I., Tkachuk A., Gushchin V., Netesov S., Magnius L.O., Norder Heléne
A total of 381 hepatitis B virus (HBV) DNA sequences collected from nine groups of Siberian native
Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination
Asadi Mobarkhan F.A., Manuylov V.A., Karlsen A.A., Kichatova V.S., Potemkin I.A., Lopatukhina M.A., Isaeva O.V., Mullin E.V., Mazunina E.P., Bykonia E.N., Kleymenov D.A., Popova L.I., Gushchin V.A., Tkachuk A.P., Saryglar A.A., Kravchenko I.E., Sleptsova S.S., Romanenko V.V., Kuznetsova A.V., Solonin S.A., Semenenko T.A., Mikhailov M.I., Kyuregyan K.K.
A neonatal vaccination against the Hepatitis B virus (HBV) infection was initiated in Russia 20
Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage
Kyuregyan K.K., Lopatukhina M.A., Asadi Mobarkhan F.A., Kichatova V.S., Potemkin I.A., Isaeva O.V., Karlsen A.A., Malinnikova E.Y., Kaira A.N., Kozhanova T.V., Manuylov V.A., Mazunina E.P., Bykonia E.N., Kleymenov D.A., Ignateva M.E., Trotsenko O.E., Kuznetsova A.V., Saryglar A.A., Oorzhak N.D., Romanenko V.V., Mikhailov M.I.
The data on hepatitis A virus (HAV) seroprevalence are critical for the implementation of a
Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination
Isaeva O.V., Kyuregyan K.K., Karlsen A.A., Kuzmin O.V., Potemkin I.A., Kichatova V.S., Asadi Mobarkhan F.A., Mullin E.V., Kozhanova T.V., Manuylov V.A., Pochtovyy A.A., Gushchin V.A., Saryglar A.A., Ilchenko L.Y., Mikhailov M.I.
The hepatitis delta virus (HDV) is believed to be a vanishing infection in countries

Страница 1 из 33995

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core